13 results on '"Hyundai Hope On Wheels"'
Search Results
2. UNC Childhood, Adolescent, and Young Adult Cancer Cohort (UNC-CAYACC)
- Author
-
Hyundai Hope On Wheels
- Published
- 2024
3. Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors (AflacST1502)
- Author
-
Cannonball Kids' Cancer Foundation, Hyundai Hope On Wheels, and Thomas Cash, Associate Professor
- Published
- 2024
4. HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors
- Author
-
Food and Drug Administration (FDA), National Center for Advancing Translational Sciences of the National Institutes of Health, Cannonball Kids' Cancer Foundation, Rally Foundation for Childhood Cancer Research, Hyundai Hope On Wheels, St. Baldrick's Foundation, United States Department of Defense, Andrew McDonough B+ Foundation, Kaul Pediatric Research Institute, NIH/National Cancer Institute Cancer Center Support Grants to the University of Alabama at Birmingham, Memorial Sloan Kettering Cancer Center, Kelsie's Crew, Eli's Block Party Childhood Cancer Foundation, Eli Jackson Foundation, Jaxon's F.R.O.G. Foundation, Battle for a Cure Foundation, Sandcastle Kids, and Gregory K. Friedman, MD, Principal investigator
- Published
- 2024
5. Monitoring and Treatment of Relapsed Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation in Children
- Author
-
Millennium Pharmaceuticals, Inc., Hyundai Hope On Wheels, and Reuven Schore, MD
- Published
- 2023
6. Phase I, Dose Escalation Study of Decitabine
- Author
-
Hyundai Hope On Wheels
- Published
- 2018
7. Sirolimus With Cyclophosphamide and Topotecan for Pediatric/Adolescent Relapsed and Refractory Solid Tumors
- Author
-
Hyundai Hope On Wheels
- Published
- 2017
8. Surface Lattice Plasmon Resonances by Direct In Situ Substrate Growth of Gold Nanoparticles in Ordered Arrays
- Author
-
Ministerio de Ciencia, Innovación y Universidades (España), Consejo Superior de Investigaciones Científicas (España), Fundación la Caixa, University of California, National Institute for Health and Care Research (US), Hyundai Hope On Wheels, National Science Foundation (US), Vinnacombe-Willson, Gail A, Conti, Ylli, Jonas, Steven J, Weiss, Paul S, Mihi, Agustín, Scarabelli, Leonardo, Ministerio de Ciencia, Innovación y Universidades (España), Consejo Superior de Investigaciones Científicas (España), Fundación la Caixa, University of California, National Institute for Health and Care Research (US), Hyundai Hope On Wheels, National Science Foundation (US), Vinnacombe-Willson, Gail A, Conti, Ylli, Jonas, Steven J, Weiss, Paul S, Mihi, Agustín, and Scarabelli, Leonardo
- Abstract
Precise arrangements of plasmonic nanoparticles on substrates are important for designing optoelectronics, sensors and metamaterials with rational electronic, optical and magnetic properties. Bottom-up synthesis offers unmatched control over morphology and optical response of individual plasmonic building blocks. Usually, the incorporation of nanoparticles made by bottom-up wet chemistry starts from batch synthesis of colloids, which requires time-consuming and hard-to-scale steps like ligand exchange and self-assembly. Herein, an unconventional bottom-up wet-chemical synthetic approach for producing gold nanoparticle ordered arrays is developed. Water-processable hydroxypropyl cellulose stencils facilitate the patterning of a reductant chemical ink on which nanoparticle growth selectively occurs. Arrays exhibiting lattice plasmon resonances in the visible region and near infrared (quality factors of >20) are produced following a rapid synthetic step (<10 min), all without cleanroom fabrication, specialized equipment, or self-assembly, constituting a major step forward in establishing in situ growth approaches. Further, the technical capabilities of this method through modulation of the particle size, shape, and array spacings directly on the substrate are demonstrated. Ultimately, establishing a fundamental understanding of in situ growth has the potential to inform the fabrication of plasmonic materials; opening the door for in situ growth fabrication of waveguides, lasing platforms, and plasmonic sensors.
- Published
- 2022
9. Large-Scale Soft-Lithographic Patterning of Plasmonic Nanoparticles
- Author
-
European Commission, European Research Council, Ministerio de Economía y Competitividad (España), National Institute of Biomedical Imaging and Bioengineering (US), National Institute of Dental and Craniofacial Research (US), Alex's Lemonade Stand Foundation for Childhood Cancer, Hyundai Hope On Wheels, National Science Foundation (US), UCLA Clinical and Translational Science Institute, Chiang, Naihao, Scarabelli, Leonardo, Vinnacombe-Willson, Gail A., Pérez, Luis Alberto, Dore, Camilla, Mihi, Agustín, Jonas, Steven J., Weiss, Paul S., European Commission, European Research Council, Ministerio de Economía y Competitividad (España), National Institute of Biomedical Imaging and Bioengineering (US), National Institute of Dental and Craniofacial Research (US), Alex's Lemonade Stand Foundation for Childhood Cancer, Hyundai Hope On Wheels, National Science Foundation (US), UCLA Clinical and Translational Science Institute, Chiang, Naihao, Scarabelli, Leonardo, Vinnacombe-Willson, Gail A., Pérez, Luis Alberto, Dore, Camilla, Mihi, Agustín, Jonas, Steven J., and Weiss, Paul S.
- Abstract
Micro- and nanoscale patterned monolayers of plasmonic nanoparticles were fabricated by combining concepts from colloidal chemistry, self-assembly, and subtractive soft lithography. Leveraging chemical interactions between the capping ligands of pre-synthesized gold colloids and a polydimethylsiloxane stamp, we demonstrated patterning gold nanoparticles over centimeter-scale areas with a variety of micro- and nanoscale geometries, including islands, lines, and chiral structures (e.g., square spirals). By successfully achieving nanoscale manipulation over a wide range of substrates and patterns, we established a powerful and straightforward strategy, nanoparticle chemical lift-off lithography (NP-CLL), for the economical and scalable fabrication of functional plasmonic materials with colloidal nanoparticles as building blocks, offering a transformative solution for designing next-generation plasmonic technologies.
- Published
- 2021
10. The Second Oncogenic Hit Determines the Cell Fate of ETV6-RUNX1 Positive Leukemia
- Author
-
Instituto de Salud Carlos III, European Commission, Ministerio de Economía y Competitividad (España), Agencia Estatal de Investigación (España), Ministerio de Ciencia, Innovación y Universidades (España), Junta de Castilla y León, Fundación Unoentrecienmil, Hyundai Hope On Wheels, Universidad de Salamanca, Banco Santander, Rodríguez-Hernández, Guillermo, Casado-García, Ana, Isidro‑Hernández, Marta, Picard, Daniel, Raboso-Gallego, Javier, Alemán-Arteaga, Silvia, Orfao, Alberto, Blanco, Óscar, Riesco, Susana, Prieto-Matos, Pablo, García-Criado, Francisco Javier, García-Cenador, Begoña, Hock, Hanno, Enver, Tariq, Sánchez García, Isidro, Vicente-Dueñas, Carolina, Instituto de Salud Carlos III, European Commission, Ministerio de Economía y Competitividad (España), Agencia Estatal de Investigación (España), Ministerio de Ciencia, Innovación y Universidades (España), Junta de Castilla y León, Fundación Unoentrecienmil, Hyundai Hope On Wheels, Universidad de Salamanca, Banco Santander, Rodríguez-Hernández, Guillermo, Casado-García, Ana, Isidro‑Hernández, Marta, Picard, Daniel, Raboso-Gallego, Javier, Alemán-Arteaga, Silvia, Orfao, Alberto, Blanco, Óscar, Riesco, Susana, Prieto-Matos, Pablo, García-Criado, Francisco Javier, García-Cenador, Begoña, Hock, Hanno, Enver, Tariq, Sánchez García, Isidro, and Vicente-Dueñas, Carolina
- Abstract
ETV6-RUNX1 is almost exclusively associated with childhood B-cell acute lymphoblastic leukemia (B-ALL), but the consequences of ETV6-RUNX1 expression on cell lineage decisions during B-cell leukemogenesis are completely unknown. Clinically silent ETV6-RUNX1 preleukemic clones are frequently found in neonatal cord blood, but few carriers develop B-ALL as a result of secondary genetic alterations. The understanding of the mechanisms underlying the first transforming steps could greatly advance the development of non-toxic prophylactic interventions. Using genetic lineage tracing, we examined the capacity of ETV6-RUNX1 to instruct a malignant phenotype in the hematopoietic lineage by cell-specific Cre-mediated activation of ETV6-RUNX1 from the endogenous Etv6 gene locus. Here we show that, while ETV6-RUNX1 has the propensity to trigger both T- and B-lymphoid malignancies, it is the second hit that determines tumor cell identity. To instigate leukemia, both oncogenic hits must place early in the development of hematopoietic/precursor cells, not in already committed B-cells. Depending on the nature of the second hit, the resulting B-ALLs presented distinct entities that were clearly separable based on their gene expression profiles. Our findings give a novel mechanistic insight into the early steps of ETV6-RUNX1+ B-ALL development and might have major implications for the potential development of ETV6-RUNX1+ B-ALL prevention strategies.
- Published
- 2021
11. Surface Lattice Plasmon Resonances by Direct In Situ Substrate Growth of Gold Nanoparticles in Ordered Arrays
- Author
-
Gail A. Vinnacombe‐Willson, Ylli Conti, Steven J. Jonas, Paul S. Weiss, Agustín Mihi, Leonardo Scarabelli, Ministerio de Ciencia, Innovación y Universidades (España), Consejo Superior de Investigaciones Científicas (España), Fundación 'la Caixa', University of California, National Institute for Health and Care Research (US), Hyundai Hope On Wheels, and National Science Foundation (US)
- Subjects
In situ growth ,Bottom-up synthesis ,Mechanics of Materials ,Mechanical Engineering ,Lattice plasmon resonance ,Plasmonic arrays ,General Materials Science - Abstract
Precise arrangements of plasmonic nanoparticles on substrates are important for designing optoelectronics, sensors and metamaterials with rational electronic, optical and magnetic properties. Bottom-up synthesis offers unmatched control over morphology and optical response of individual plasmonic building blocks. Usually, the incorporation of nanoparticles made by bottom-up wet chemistry starts from batch synthesis of colloids, which requires time-consuming and hard-to-scale steps like ligand exchange and self-assembly. Herein, an unconventional bottom-up wet-chemical synthetic approach for producing gold nanoparticle ordered arrays is developed. Water-processable hydroxypropyl cellulose stencils facilitate the patterning of a reductant chemical ink on which nanoparticle growth selectively occurs. Arrays exhibiting lattice plasmon resonances in the visible region and near infrared (quality factors of >20) are produced following a rapid synthetic step (, The authors thank Camilla Dore for her advice and contributed expertise on the fabrication of HPC films. The authors extend their gratitude to Jose Mendoza Carreño for his assistance with the optical characterization of the gold nanoparticle arrays. This project had received funding from the Spanish Ministry of Science and Innovation through grants FUNFUTURE (CEX2019-000917-S), (FUNFUTURE, in the framework of the Spanish Severo Ochoa Centre of Excellence program) and PID2019-106860GB-I00 (HIGHN). L.S. and A.M. thank the Spanish National Research Council (CSIC) for funding via the I-LINK 2020 international travel grant, which facilitated international exchange period necessary for completion of this work. L.S. and Y.C. research is supported by the 2020 Post-doctoral Junior Leader-Incoming Fellowship by “la Caixa” Foundation (ID 100010434, fellow-ship code LCF/BQ/PI20/11760028). Y.C. acknowledges the auspices of the UAB material science doctoral program. G.A.V.W. thanks the UCLA graduate division for funding through the University of California Office of the President Dissertation Year Fellowship. S.J.J. acknowledges support from the National Institutes of Health (NIH) Common Fund through a NIH Director's Early Independence Award co-funded by the National Institute of Dental and Craniofacial Research and Office of the Director, NIH Grant DP5OD028181. S.J.J. and G.A.V.W. acknowledge support through a Scholar Award from the Hyundai Hope on Wheels Foundation for Pediatric Cancer Research. P.S.W. thanks the National Science Foundation for support through Grant #CHE-2004238., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000917-S).
- Published
- 2022
12. Large-Scale Soft-Lithographic Patterning of Plasmonic Nanoparticles
- Author
-
Leonardo Scarabelli, Naihao Chiang, Agustín Mihi, Paul S. Weiss, Gail A. Vinnacombe-Willson, Luis Alberto Pérez, Camilla Dore, Steven J. Jonas, European Commission, European Research Council, Ministerio de Economía y Competitividad (España), National Institute of Biomedical Imaging and Bioengineering (US), National Institute of Dental and Craniofacial Research (US), Alex's Lemonade Stand Foundation for Childhood Cancer, Hyundai Hope On Wheels, National Science Foundation (US), and UCLA Clinical and Translational Science Institute
- Subjects
Plasmonic nanoparticles ,Materials science ,General Chemical Engineering ,Interface and colloid science ,Biomedical Engineering ,Nanoparticle ,Bioengineering ,Nanotechnology ,02 engineering and technology ,010402 general chemistry ,021001 nanoscience & nanotechnology ,01 natural sciences ,Soft lithography ,Article ,3. Good health ,0104 chemical sciences ,Colloidal gold ,General Materials Science ,0210 nano-technology ,Nanoscopic scale ,Lithography ,Plasmon - Abstract
Micro- and nanoscale patterned monolayers of plasmonic nanoparticles were fabricated by combining concepts from colloidal chemistry, self-assembly, and subtractive soft lithography. Leveraging chemical interactions between the capping ligands of pre-synthesized gold colloids and a polydimethylsiloxane stamp, we demonstrated patterning gold nanoparticles over centimeter-scale areas with a variety of micro- and nanoscale geometries, including islands, lines, and chiral structures (e.g., square spirals). By successfully achieving nanoscale manipulation over a wide range of substrates and patterns, we established a powerful and straightforward strategy, nanoparticle chemical lift-off lithography (NP-CLL), for the economical and scalable fabrication of functional plasmonic materials with colloidal nanoparticles as building blocks, offering a transformative solution for designing next-generation plasmonic technologies., The authors would like to thank the Nanoquim clean room facility at ICMAB-CSIC and, in particular, Dr. Luigi Morrone for help with the use of the microwriter for master preparation. We acknowledge the CNSI-EICN, ICMAB-CSIC, and ICN2 electron microscopy facilities for TEM and SEM imaging, WiTEC for access to their microscopy instrumentation, and Dr. Thomas Young and Michael Mellody for the preparation of silicon masters. Special thanks to Dr. Leonora Velleman for the fruitful discussion on nanoparticle self-assembly. L.S. research is supported by the Marie Sklodowska-Curie Actions SHINE (H2020-MSCA-IF-2019, grant agreement No. 894847) and the 2020 Post-doctoral Junior Leader-Incoming Fellowship by “la Caixa” Foundation (ID 100010434, fellowship code LCF/BQ/PI20/11760028). L.A.P. thanks the Marie Sklodowska-Curie Actions (H2020-MSCA-IF-2018) for grant agreement No. 839402, PLASMIONICO. L.S., L.A.P., C.D., and A.M. acknowledge funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (Grant Agreement No. 637116, ENLIGHTMENT). ICMAB acknowledges the Spanish Ministry of Economy and Competitiveness under grants PID2019-106860GB-I00 (AEI/FEDER, UE) and FUNFUTURE (CEX2019-000917-S) center of excellence Severo Ochoa program. This work has been performed in the framework of the doctorate in Materials Science of the Autonomous University of Barcelona. N.C. thanks the NIH NIBIB Pathway to Independence Award (K99EB028325) for support. S.J.J. is supported by the NIH Common Fund through a NIH Director’s Early Independence Award co-funded by the National Institute of Dental and Craniofacial Research and Office of the Director, NIH Grant DP5OD028181. S.J.J. also acknowledges Young Investigator Award funds from the Alex’s Lemonade Stand Foundation for Childhood Cancer Research and the Hyundai Hope on Wheels Foundation for Pediatric Cancer Research. P.S.W. thanks the National Science Foundation (2004238) for support of this work. Funds for core facility use were provided via a support voucher awarded to N.C. and S.J.J. via the UCLA Clinical and Translational Science Institute (CTSI) Core Voucher Program, which is administered through Grant Number UL1TR001881.
- Published
- 2021
13. The Second Oncogenic Hit Determines the Cell Fate of ETV6-RUNX1 Positive Leukemia
- Author
-
Guillermo Rodríguez-Hernández, Ana Casado-García, Marta Isidro-Hernández, Daniel Picard, Javier Raboso-Gallego, Silvia Alemán-Arteaga, Alberto Orfao, Oscar Blanco, Susana Riesco, Pablo Prieto-Matos, Francisco Javier García Criado, María Begoña García Cenador, Hanno Hock, Tariq Enver, Isidro Sanchez-Garcia, Carolina Vicente-Dueñas, Instituto de Salud Carlos III, European Commission, Ministerio de Economía y Competitividad (España), Agencia Estatal de Investigación (España), Ministerio de Ciencia, Innovación y Universidades (España), Junta de Castilla y León, Fundación Unoentrecienmil, Hyundai Hope On Wheels, Universidad de Salamanca, and Banco Santander
- Subjects
0301 basic medicine ,Childhood leukemia ,Germline ,Somatic cell ,QH301-705.5 ,B-cell ,Biology ,Cell fate determination ,germline ,Mouse models ,03 medical and health sciences ,Cell and Developmental Biology ,0302 clinical medicine ,hemic and lymphatic diseases ,transcription factors ,medicine ,Transcription factors ,mouse models ,Somatic ,Biology (General) ,B cell ,Original Research ,somatic ,childhood leukemia ,Cell Biology ,medicine.disease ,Haematopoiesis ,ETV6 ,Leukemia ,030104 developmental biology ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Cord blood ,embryonic structures ,Cancer research ,Developmental Biology - Abstract
© 2021 Rodríguez-Hernández, Casado-García, Isidro-Hernández, Picard, Raboso-Gallego, Alemán-Arteaga, Orfao, Blanco, Riesco, Prieto-Matos, García Criado, García Cenador, Hock, Enver, Sanchez-Garcia and Vicente-Dueñas., ETV6-RUNX1 is almost exclusively associated with childhood B-cell acute lymphoblastic leukemia (B-ALL), but the consequences of ETV6-RUNX1 expression on cell lineage decisions during B-cell leukemogenesis are completely unknown. Clinically silent ETV6-RUNX1 preleukemic clones are frequently found in neonatal cord blood, but few carriers develop B-ALL as a result of secondary genetic alterations. The understanding of the mechanisms underlying the first transforming steps could greatly advance the development of non-toxic prophylactic interventions. Using genetic lineage tracing, we examined the capacity of ETV6-RUNX1 to instruct a malignant phenotype in the hematopoietic lineage by cell-specific Cre-mediated activation of ETV6-RUNX1 from the endogenous Etv6 gene locus. Here we show that, while ETV6-RUNX1 has the propensity to trigger both T- and B-lymphoid malignancies, it is the second hit that determines tumor cell identity. To instigate leukemia, both oncogenic hits must place early in the development of hematopoietic/precursor cells, not in already committed B-cells. Depending on the nature of the second hit, the resulting B-ALLs presented distinct entities that were clearly separable based on their gene expression profiles. Our findings give a novel mechanistic insight into the early steps of ETV6-RUNX1+ B-ALL development and might have major implications for the potential development of ETV6-RUNX1+ B-ALL prevention strategies., Research in CV-D group has been funded by Instituto de Salud Carlos III through the project “PI17/00167” and by a “Miguel Servet Grant” (CPII19/00024—AES 2017–2020), co-funded by European Regional Development Fund/European Social Fund (“A way to make Europe”/“Investing in your future”). Research in the IS-G group is partially supported by FEDER and SAF2015-64420-R MINECO/FEDER, UE, RTI2018-093314-B-I00 MCIU/AEI/FEDER, UE, and by Junta de Castilla y León (UIC-017, CSI001U16, CSI234P18, and CSI144P20). The IS-G lab is a member of the EuroSyStem and the DECIDE Network funded by the European Union under the FP7 program. CV-D and IS-G have been supported by the German Federal Office for Radiation Protection (BfS)–Germany (FKZ: 3618S32274). IS-G has been supported by the Fundacion Unoentrecienmil (CUNINA project). HH was supported by a Hyundai Hope on Wheels scholar grant. GR-H was supported by FSE-Conserjería de Educación de la Junta de Castilla y León (CSI001-15). AC-G and MI-H are supported by FSE-Conserjería de Educación de la Junta de Castilla y León 2019 and 2020 (ESF—European Social Fund) fellowship, respectively (REF. CSI067-18 and CSI021-19). JR-G was supported by a scholarship from the University of Salamanca, co-financed by Banco Santander and ESF. SA-A was supported by RTI2018-093314-B-I00 MCIU/AEI/FEDER fellowship (PRE2019-088887).
- Published
- 2021
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.